Featuring

What the future holds for real-time PCR
Dr Mikael Kubista, TATAA Biocenter, Sweden, and the Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic

Stem cell research and therapeutic innovation: not always a long-term perspective
Claudio Bordignon, CEO of Molmed and Professor of Haematology, Vita-Salute San Raffaele University

Future trends for proteomics
Daniel Boismenu, Laboratory Manager, Montreal Proteomics Network

The changing role of automation in High Throughput Screening
Ulrich Schopfer, Director and Head of Biochemical Screening, Novartis Institutes for BioMedical Research

2008 PAT Initiative Review
Martin Warman, Director, MWC Ltd

The increasing use of Microbial Genotypic Techniques for the Identification of Pharmaceutical Isolates
Andrew Middleton, Group Leader, CHRε^_tD Microbiology, GlaxoSmithKline

If you wish to view the magazine in digital format, please click HERE